These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
394 related articles for article (PubMed ID: 18487097)
1. Effects of topical administration of 1% brinzolamide on intraocular pressure in clinically normal horses. Germann SE; Matheis FL; Rampazzo A; Burger D; Roos M; Spiess BM Equine Vet J; 2008 Nov; 40(7):662-5. PubMed ID: 18487097 [TBL] [Abstract][Full Text] [Related]
2. Intraocular pressure reduction with travoprost/timolol fixed combination, with and without adjunctive brinzolamide, in glaucoma. Holló G; Kóthy P Curr Med Res Opin; 2008 Jun; 24(6):1755-61. PubMed ID: 18479590 [TBL] [Abstract][Full Text] [Related]
3. Effect of topical brinzolamide 1% and brimonidine 0.2% on intraocular pressure after phacoemulsification. Cetinkaya A; Akman A; Akova YA J Cataract Refract Surg; 2004 Aug; 30(8):1736-41. PubMed ID: 15313300 [TBL] [Abstract][Full Text] [Related]
4. Intraocular pressure-lowering efficacy of brinzolamide 1%/timolol 0.5% fixed combination compared with brinzolamide 1% and timolol 0.5%. Kaback M; Scoper SV; Arzeno G; James JE; Hua SY; Salem C; Dickerson JE; Landry TA; Bergamini MV; Ophthalmology; 2008 Oct; 115(10):1728-34, 1734.e1-2. PubMed ID: 18538406 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the ocular hypotensive efficacy of adjunctive brimonidine 0.15% or brinzolamide 1% in combination with travoprost 0.004%. Feldman RM; Tanna AP; Gross RL; Chuang AZ; Baker L; Reynolds A; Prager TC; Ophthalmology; 2007 Jul; 114(7):1248-54. PubMed ID: 17509688 [TBL] [Abstract][Full Text] [Related]
6. Brinzolamide 1%/timolol 0.5%: safety and efficacy of a new fixed-combination IOP-lowering product for glaucoma. Januleviciene I Curr Med Res Opin; 2010 Nov; 26(11):2575-8. PubMed ID: 20868340 [TBL] [Abstract][Full Text] [Related]
7. Effects of topical administration of 1% brinzolamide on normal cat eyes. Gray HE; Willis AM; Morgan RV Vet Ophthalmol; 2003 Dec; 6(4):285-90. PubMed ID: 14641824 [TBL] [Abstract][Full Text] [Related]
8. Medical control of intraocular pressure after phacoemulsification. Dayanir V; Ozcura F; Kir E; Topaloğlu A; Ozkan SB; Aktunç T J Cataract Refract Surg; 2005 Mar; 31(3):484-8. PubMed ID: 15811735 [TBL] [Abstract][Full Text] [Related]
9. Brinzolamide/timolol fixed combination: a new ocular suspension for the treatment of open-angle glaucoma and ocular hypertension. Holló G; Bozkurt B; Irkec M Expert Opin Pharmacother; 2009 Aug; 10(12):2015-24. PubMed ID: 19618994 [TBL] [Abstract][Full Text] [Related]
10. Medical control of intraocular pressure with brinzolamide 1% after phacoemulsification. Kir E; Cakmak H; Dayanir V Can J Ophthalmol; 2008 Oct; 43(5):559-62. PubMed ID: 18982032 [TBL] [Abstract][Full Text] [Related]
11. Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs. Bournias TE; Lai J Ophthalmology; 2009 Sep; 116(9):1719-24. PubMed ID: 19592108 [TBL] [Abstract][Full Text] [Related]
12. Ocular hypotensive effect and safety of brinzolamide ophthalmic solution in open angle glaucoma patients. Wang TH; Huang JY; Hung PT; Shieh JW; Chen YF J Formos Med Assoc; 2004 May; 103(5):369-73. PubMed ID: 15216404 [TBL] [Abstract][Full Text] [Related]
13. Comparing diurnal and nocturnal effects of brinzolamide and timolol on intraocular pressure in patients receiving latanoprost monotherapy. Liu JH; Medeiros FA; Slight JR; Weinreb RN Ophthalmology; 2009 Mar; 116(3):449-54. PubMed ID: 19157559 [TBL] [Abstract][Full Text] [Related]
14. Comparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprost. Miura K; Ito K; Okawa C; Sugimoto K; Matsunaga K; Uji Y J Glaucoma; 2008; 17(3):233-7. PubMed ID: 18414111 [TBL] [Abstract][Full Text] [Related]
15. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension. Manni G; Denis P; Chew P; Sharpe ED; Orengo-Nania S; Coote MA; Laganovska G; Volksone L; Zeyen T; Filatori I; James J; Aung T J Glaucoma; 2009; 18(4):293-300. PubMed ID: 19365194 [TBL] [Abstract][Full Text] [Related]
16. Effect of concomitant use of latanoprost and brinzolamide on 24-hour variation of IOP in normal-tension glaucoma. Nakamoto K; Yasuda N J Glaucoma; 2007; 16(4):352-7. PubMed ID: 17570997 [TBL] [Abstract][Full Text] [Related]
17. [Decrease in intraocular pressure following administration of the local carbonic anhydrase inhibitor (MK-927)--comparison of the effect with pilocarpine]. Pfeiffer N; Grehn F; Hennekes R; Garus H Fortschr Ophthalmol; 1990; 87(2):128-30. PubMed ID: 2192972 [TBL] [Abstract][Full Text] [Related]
19. Effects of topical 2% dorzolamide hydrochloride alone and in combination with 0.5% timolol maleate on intraocular pressure in normal feline eyes. Dietrich UM; Chandler MJ; Cooper T; Vidyashankar A; Chen G Vet Ophthalmol; 2007; 10 Suppl 1():95-100. PubMed ID: 17973840 [TBL] [Abstract][Full Text] [Related]
20. Changes in intraocular pressure associated with topical dorzolamide and oral methazolamide in glaucomatous dogs. Gelatt KN; MacKay EO Vet Ophthalmol; 2001 Mar; 4(1):61-7. PubMed ID: 11397321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]